Wegovy Maker to Limit Starter-Dose Supplies in U.S. as Demand Surges
Wall Street Journal
Lower-strength starter doses of the obesity drug will be held back in the U.S. to safeguard supplies, said pharmaceutical company Novo Nordisk.
Understanding current events through the lenses of the past and future.
Wall Street Journal
Lower-strength starter doses of the obesity drug will be held back in the U.S. to safeguard supplies, said pharmaceutical company Novo Nordisk.